Mark Verratti - Mar 24, 2023 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Chief Commercial Officer
Signature
By: Justin Hunter For: Mark Verratti
Stock symbol
MYGN
Transactions as of
Mar 24, 2023
Transactions value $
-$63,309
Form type
4
Date filed
3/27/2023, 04:27 PM
Previous filing
Mar 23, 2023
Next filing
Apr 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Tax liability -$25.7K -1.08K -0.41% $23.72 265K Mar 24, 2023 Direct F1
transaction MYGN Common Stock Tax liability -$37.6K -1.59K -0.6% $23.72 263K Mar 24, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023.
F2 Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023.